RK
Raj Kumar
About Raj Kumar
Data last updated:
Raj Kumar is an Additional Director at Biogenetic Drugs Private Limited (since 2025) and Designated Partner at Cynamid Pharmachem Llp (since 2020). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Biogenetic Drugs Private Limited at ₹115 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biogenetic Drugs Private Limited U24232RJ2004PTC018909 | Additional Director | 27 Feb 2025 | 2004 | ₹115 Cr (FY 2025) | Active |
 Cynamid Pharmachem Llp AAM-9692 | Designated Partner | 01 Oct 2020 | 2018 | Active |
Board colleagues of Raj Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mukut Bihari Goyal | 00222379 | Biogenetic Drugs Private Limited , Cynamid Pharmachem Llp | Director |
| Vibhor Goyal | 03614002 | Biogenetic Drugs Private Limited , Cynamid Pharmachem Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raj Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raj Kumar
Raj Kumar currently holds 2 directorships: Biogenetic Drugs Private Limited (Additional Director, since 27 Feb 2025, revenue ₹115 Cr (FY 2025)); Cynamid Pharmachem Llp (Designated Partner, since 01 Oct 2020).
Raj Kumar was first appointed on 01 Oct 2020 as Designated Partner at Cynamid Pharmachem Llp. The most recent appointment on record is 27 Feb 2025 at Biogenetic Drugs Private Limited.
The current boards of Raj Kumar's companies include Mukut Bihari Goyal (Biogenetic Drugs Private Limited), Vibhor Goyal (Biogenetic Drugs Private Limited).